These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25252734)

  • 41. Simultaneous intra-operative sclerotherapy and surgical resection of cervicofacial venous malformations.
    MacArthur CJ; Nesbit G
    Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():143-146. PubMed ID: 30634101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Venous malformations of the head and neck: current concepts in management.
    Fowell C; Verea Linares C; Jones R; Nishikawa H; Monaghan A
    Br J Oral Maxillofac Surg; 2017 Jan; 55(1):3-9. PubMed ID: 27894790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
    Khandpur S; Sharma VK
    Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-time MRI-guided percutaneous sclerotherapy treatment of venous low-flow malformations in the head and neck.
    Partovi S; Lu Z; Vidal L; Nakamoto DA; Buethe J; Coffey M; Patel IJ
    Phlebology; 2018 Jun; 33(5):344-352. PubMed ID: 28516809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sclerotherapy of peripheral low-flow vascular malformations: technical aspects and mid-term clinical outcome.
    Giurazza F; Corvino F; Cangiano G; Amodio F; Cavaglià E; Silvestre M; De Magistris G; Tecame S; Niola R
    Radiol Med; 2018 Jun; 123(6):474-480. PubMed ID: 29476439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies.
    Mason KP; Neufeld EJ; Karian VE; Zurakowski D; Koka BV; Burrows PE
    AJR Am J Roentgenol; 2001 Dec; 177(6):1359-63. PubMed ID: 11717083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Venous Malformations of the Head and Neck.
    Seront E; Vikkula M; Boon LM
    Otolaryngol Clin North Am; 2018 Feb; 51(1):173-184. PubMed ID: 29217061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-flow vascular malformations of the head and neck: clinicopathology and image guided therapy.
    Love Z; Hsu DP
    J Neurointerv Surg; 2012 Nov; 4(6):414-25. PubMed ID: 21990544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contemporary Management of Vascular Anomalies of the Head and Neck-Part 1: Vascular Malformations: A Review.
    Gallant SC; Chewning RH; Orbach DB; Trenor CC; Cunningham MJ
    JAMA Otolaryngol Head Neck Surg; 2021 Feb; 147(2):197-206. PubMed ID: 33237296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vascular medicine and foam sclerotherapy for venous malformations].
    Blaise S
    J Med Vasc; 2017 Oct; 42(5):315-319. PubMed ID: 28964390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Venous disorders: treatment with sclerosant foam.
    Bergan J; Pascarella L; Mekenas L
    J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new automated system for the preparation of sclerosant foam: A study of the physical characteristics produced and the device settings required.
    Roche E; Pons R; Roche O; Puig A
    Phlebology; 2020 Oct; 35(9):724-733. PubMed ID: 32635818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 6-year experience treating vascular malformations with foam sclerotherapy.
    Markovic JN; Kim CY; Lidsky ME; Shortell CK
    Perspect Vasc Surg Endovasc Ther; 2012 Jun; 24(2):70-9. PubMed ID: 22918935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Head and neck superficial venous malformations].
    Sigaux N; Viremouneix L; Guibaud L; Breton P
    Rev Stomatol Chir Maxillofac Chir Orale; 2015 Sep; 116(4):201-8. PubMed ID: 26296277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck.
    Kaji N; Kurita M; Ozaki M; Takushima A; Harii K; Narushima M; Wakita S
    Scand J Plast Reconstr Surg Hand Surg; 2009; 43(3):126-36. PubMed ID: 19401940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience.
    Cahill AM; Nijs E; Ballah D; Rabinowitz D; Thompson L; Rintoul N; Hedrick H; Jacobs I; Low D
    J Pediatr Surg; 2011 Nov; 46(11):2083-95. PubMed ID: 22075337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanochemical ablation causes endothelial and medial damage to the vein wall resulting in deeper penetration of sclerosant compared with sclerotherapy alone in extrafascial great saphenous vein using an ex vivo model.
    Whiteley MS; Dos Santos SJ; Lee CT; Li JM
    J Vasc Surg Venous Lymphat Disord; 2017 May; 5(3):370-377. PubMed ID: 28411705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intra-abdominal lymphatic malformation management in light of the updated International Society for the Study of Vascular Anomalies classification.
    Elbaaly H; Piché N; Rypens F; Kleiber N; Lapierre C; Dubois J
    Pediatr Radiol; 2021 May; 51(5):760-772. PubMed ID: 33559726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.